Poop pills could save kids from deadly transplant complication
NCT ID NCT07602751
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study tests whether fecal microbiota transplantation (FMT) is safe and possible for children and young adults (ages 3 months to 25 years) with severe gut graft-versus-host disease (GVHD) that does not respond to steroids. GVHD is a serious complication after a bone marrow transplant where donor cells attack the patient's body. Participants will receive 1 to 3 FMT treatments via a tube into the intestine. The main goal is to check for side effects, and the study also looks at whether the treatment helps control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital
Roma, 00165, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, 40138, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UOC Clinica di Oncoematologia Pediatrica, Azienda Ospedale-Università Padova
Padova, 35128, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.